Wright Investors Service’s 10x Genomics TXG Stock Holding History

Wright Investors Service’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,384	Closed	-$504K	–	168
2021 Q4	$504K	Sell	3,384 -1,146	-25%	-$176K	0.13%	122
2021 Q3	$659K	Buy	4,530 +404	+10%	+$69.4K	0.19%	115
2021 Q2	$808K	Buy	4,126 +68	+2%	+$12.3K	0.22%	107
2021 Q1	$734K	Sell	4,058 -20	-0.5%	-$3.45K	0.22%	116
2020 Q4	$577K	Sell	4,078 -355	-8%	-$51.5K	0.2%	116
2020 Q3	$553K	Buy	+4,433	New	+$465K	0.2%	107

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wright Investors Service's TXG Position: Q1 2022 in Review

Wright Investors Service sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 3,384 shares — an estimated $504K sold.

Wright Investors Service first reported a position in TXG in Q3 2020 and held it in 6 quarters. The position peaked at $808K in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

Wright Investors Service reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
Wright Investors Service sold 3,384 10x Genomics shares in Q1 2022, an estimated $504K.
Wright Investors Service first reported a position in 10x Genomics in Q3 2020 and held it in 6 quarters.
Wright Investors Service's 10x Genomics position peaked at $808K in Q2 2021.
314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on Wright Investors Service's 13F filing for Q1 2022, filed 22 Apr 2022.